NCT06470139View on ClinicalTrials.gov

Dexamethasone for PENG Block in Total Hip Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

January 15, 2025

Study Completion Date

February 10, 2025

Conditions
Hip OsteoarthritisHip ArthropathyHip Pain Chronic
Interventions
DRUG

Ropivacaine 0.2% Injectable Solution

20ml 0.2% Ropivacaine + 2.0ml 0.9% NaCl

DRUG

Ropivacaine 0.2% Injectable Solution + 4mg Dexamethasone

20ml 0.2% Ropivacaine + 4mg Dexamethasone

Trial Locations (1)

61-701

Poznan University of Medical Sciences, Poznan

All Listed Sponsors
lead

Poznan University of Medical Sciences

OTHER

NCT06470139 - Dexamethasone for PENG Block in Total Hip Arthroplasty | Biotech Hunter | Biotech Hunter